TrademarkDir
G
LIVE

Serial Number

88294201

Owner

Inagene Diagnostics Inc.

Attorney

Matthew Warner-Blankenship

Filing Date

Feb 8, 2019

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

G Trademark

Serial Number: 88294201 • Registration: 7265524

G is a trademark filed by Inagene Diagnostics Inc. on February 8, 2019. The trademark is classified under Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Inagene Diagnostics Inc. (3 trademarks)

Toronto M4P2E5 , CA

Entity Type: 03

Trademark Details

Filing Date

February 8, 2019

Registration Date

January 9, 2024

Published for Opposition

October 24, 2023

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 9, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Jan 9, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 24, 2023 NPUB
PUBLISHED FOR OPPOSITION
Oct 24, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 4, 2023 NONP
ELECTRONIC RECORD REVIEW COMPLETE
Sep 18, 2023 FIXD
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Sep 15, 2023 ERRR
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 8, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 7, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 6, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 6, 2023 TROA
NOTIFICATION OF PRIORITY ACTION E-MAILED
Jun 6, 2023 GPRN
PRIORITY ACTION E-MAILED
Jun 6, 2023 GPRA
PRIORITY ACTION WRITTEN
Jun 6, 2023 CPRA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 15, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 15, 2023 CRFA
ASSIGNED TO LIE
Feb 14, 2023 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Feb 6, 2023 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Aug 6, 2022 GNS2
INQUIRY TO SUSPENSION E-MAILED
Aug 6, 2022 GNSI
SUSPENSION INQUIRY WRITTEN
Aug 6, 2022 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Jul 7, 2022 RCCK
ASSIGNED TO EXAMINER
Mar 7, 2022 DOCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Dec 16, 2021 GNS3
LETTER OF SUSPENSION E-MAILED
Dec 16, 2021 GNSL
SUSPENSION LETTER WRITTEN
Dec 16, 2021 CNSL
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jun 10, 2021 GNS3
LETTER OF SUSPENSION E-MAILED
Jun 10, 2021 GNSL
SUSPENSION LETTER WRITTEN
Jun 10, 2021 CNSL
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Dec 10, 2020 GNS3
LETTER OF SUSPENSION E-MAILED
Dec 10, 2020 GNSL
SUSPENSION LETTER WRITTEN
Dec 10, 2020 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 10, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 10, 2020 CRFA
ASSIGNED TO LIE
Dec 2, 2020 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Nov 2, 2020 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
May 1, 2020 GNS2
INQUIRY TO SUSPENSION E-MAILED
May 1, 2020 GNSI
SUSPENSION INQUIRY WRITTEN
May 1, 2020 CNSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Nov 1, 2019 GNS3
LETTER OF SUSPENSION E-MAILED
Nov 1, 2019 GNSL
SUSPENSION LETTER WRITTEN
Nov 1, 2019 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 28, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 28, 2019 CRFA
ASSIGNED TO LIE
Oct 23, 2019 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 17, 2019 TROA
NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Sep 24, 2019 GEAN
EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Sep 24, 2019 GEAP
COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
Sep 24, 2019 EPEN
EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Sep 24, 2019 CPEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 3, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 2, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 2, 2019 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 25, 2019 GNRN
NON-FINAL ACTION E-MAILED
Mar 25, 2019 GNRT
NON-FINAL ACTION WRITTEN
Mar 25, 2019 CNRT
ASSIGNED TO EXAMINER
Mar 25, 2019 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Mar 21, 2019 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 2, 2019 NWOS
NEW APPLICATION ENTERED
Feb 12, 2019 NWAP

Related Trademarks

More from this Owner

INAGENE DIAGNOSTICS

INAGENE DIAGNOSTICS

INAGENE DIAGNOSTICS

INAGENE DIAGNOSTICS

INAGENE DIAGNOSTICS

INAGENE DIAGNOSTICS

INAGENE

INAGENE

INAGENE

INAGENE

INAGENE

INAGENE